Literature DB >> 19515783

Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Mostafa Jarahian1, Carsten Watzl, Philippe Fournier, Annette Arnold, Dominik Djandji, Sarah Zahedi, Adelheid Cerwenka, Annette Paschen, Volker Schirrmacher, Frank Momburg.   

Abstract

The avian paramyxovirus Newcastle disease virus (NDV) selectively replicates in tumor cells and is known to stimulate T-cell-, macrophage-, and NK cell-mediated responses. The mechanisms of NK cell activation by NDV are poorly understood so far. We studied the expression of ligand structures for activating NK cell receptors on NDV-infected tumor cells. Upon infection with the nonlytic NDV strain Ulster and the lytic strain MTH-68/H, human carcinoma and melanoma cells showed enhanced expression of ligands for the natural cytotoxicity receptors NKp44 and NKp46, but not NKp30. Ligands for the activating receptor NKG2D were partially downregulated. Soluble NKp44-Fc and NKp46-Fc, but not NKp30-Fc, chimeric proteins bound specifically to NDV-infected tumor cells and to NDV particle-coated plates. Hemagglutinin-neuraminidase (HN) of the virus serves as a ligand structure for NKp44 and NKp46, as indicated by the blockade of binding to NDV-infected cells and viral particles in the presence of anti-HN antibodies and by binding to cells transfected with HN cDNA. Consistent with the recognition of sialic acid moieties by the viral lectin HN, the binding of NKp44-Fc and NKp46-Fc was lost after desialylation. NKp44- and NKp46-CD3zeta lacZ-inducible reporter cells were activated by NDV-infected cells. NDV-infected tumor cells stimulated NK cells to produce increased amounts of the effector lymphokines gamma interferon and tumor necrosis factor alpha. Primary NK cells and the NK line NK-92 lysed NDV-infected tumor cells with enhanced efficiency, an effect that was eliminated by the treatment of target cells with the neuraminidase inhibitor Neu5Ac2en. These results suggest that direct activation of NK cells contributes to the antitumor effects of NDV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515783      PMCID: PMC2715740          DOI: 10.1128/JVI.00211-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.

Authors:  V Schirrmacher; C Haas; R Bonifer; T Ahlert; R Gerhards; C Ertel
Journal:  Gene Ther       Date:  1999-01       Impact factor: 5.250

2.  MTH-68/H oncolytic viral treatment in human high-grade gliomas.

Authors:  L K Csatary; G Gosztonyi; J Szeberenyi; Z Fabian; V Liszka; B Bodey; C M Csatary
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

3.  Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.

Authors:  Oren Hershkovitz; Mostafa Jarahian; Alon Zilka; Ahuva Bar-Ilan; Guy Landau; Sergey Jivov; Yoram Tekoah; Rachel Glicklis; John T Gallagher; Sabrina C Hoffmann; Hagit Zer; Ofer Mandelboim; Carsten Watzl; Frank Momburg; Angel Porgador
Journal:  Glycobiology       Date:  2007-11-15       Impact factor: 4.313

4.  Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria.

Authors:  Semih Esin; Giovanna Batoni; Claudio Counoupas; Annarita Stringaro; Franca Lisa Brancatisano; Marisa Colone; Giuseppantonio Maisetta; Walter Florio; Giuseppe Arancia; Mario Campa
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

5.  Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application.

Authors:  Leonidas Apostolidis; Volker Schirrmacher; Philippe Fournier
Journal:  Int J Oncol       Date:  2007-11       Impact factor: 5.650

6.  Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial.

Authors:  T Schulze; W Kemmner; J Weitz; K-D Wernecke; V Schirrmacher; P M Schlag
Journal:  Cancer Immunol Immunother       Date:  2008-05-17       Impact factor: 6.968

7.  Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion.

Authors:  Viatcheslav Zaitsev; Mark von Itzstein; Darrin Groves; Milton Kiefel; Toru Takimoto; Allen Portner; Garry Taylor
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

Authors:  Elke Pogge von Strandmann; Venkateswara Rao Simhadri; Bastian von Tresckow; Stephanie Sasse; Katrin S Reiners; Hinrich P Hansen; Achim Rothe; Boris Böll; Vijaya Lakshmi Simhadri; Peter Borchmann; Peter J McKinnon; Michael Hallek; Andreas Engert
Journal:  Immunity       Date:  2007-12-06       Impact factor: 31.745

9.  Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.

Authors:  Andreina Byrd; Sabrina C Hoffmann; Mostafa Jarahian; Frank Momburg; Carsten Watzl
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

10.  Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.

Authors:  Claire Dunn; N Jan Chalupny; Claire L Sutherland; Stephanie Dosch; P V Sivakumar; David C Johnson; David Cosman
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  81 in total

Review 1.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

2.  Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.

Authors:  Julia Herrmann; Hannah Berberich; Jessica Hartmann; Steffen Beyer; Karen Davies; Joachim Koch
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

3.  The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding.

Authors:  Jessica Hartmann; Thuy-Van Tran; Janina Kaudeer; Karin Oberle; Julia Herrmann; Isabell Quagliano; Tobias Abel; André Cohnen; Volker Gatterdam; Andrea Jacobs; Bernd Wollscheid; Robert Tampé; Carsten Watzl; Andreas Diefenbach; Joachim Koch
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

Review 4.  Sialoside-based pattern recognitions discriminating infections from tissue injuries.

Authors:  Yang Liu; Guo-Yun Chen; Pan Zheng
Journal:  Curr Opin Immunol       Date:  2011-01-03       Impact factor: 7.486

Review 5.  Killers 2.0: NK cell therapies at the forefront of cancer control.

Authors:  Jonathan J Hodgins; Sarwat T Khan; Maria M Park; Rebecca C Auer; Michele Ardolino
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

Review 6.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

7.  Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.

Authors:  Paul E Leon; Wenqian He; Caitlin E Mullarkey; Mark J Bailey; Matthew S Miller; Florian Krammer; Peter Palese; Gene S Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

8.  NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Authors:  Yotam Bar-On; Yoav Charpak-Amikam; Ariella Glasner; Batya Isaacson; Alexandra Duev-Cohen; Pinchas Tsukerman; Alexander Varvak; Michal Mandelboim; Ofer Mandelboim
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 9.  Endocytosis and intracellular trafficking of human natural killer cell receptors.

Authors:  Madhan Masilamani; Giovanna Peruzzi; Francisco Borrego; John E Coligan
Journal:  Traffic       Date:  2009-08-05       Impact factor: 6.215

Review 10.  Structural insights into activation of antiviral NK cell responses.

Authors:  Kathryn A Finton; Roland K Strong
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.